Women’s Health Diagnostics Market projected to expand at a CAGR of ~6% from 2019 to 2027 – The Think Curiouser


Posted: October 21, 2020 at 12:53 am

Womens Health Diagnostics Market: Introduction

According to the report, the globalwomens health diagnostics marketwas valued at ~US$ 30.7 Bnin2018and is projected to expand at a CAGR of~6%from2019to2027.Rise in prevalence of menopause, favorable incentive and reimbursement policies for UTIs, and technical advancements are anticipated to augment the global market from 2019 to 2027. North America and Western Europe are expected to account for significant shares of the global womens health diagnostics market. Asia Pacific is projected to be a highly lucrative market for womens health diagnostics in the next few years. However, high competition is anticipated to restrain the growth of the global womens health diagnostics market.

Rise in Number of Menopausal Women to Propel Market

Menopause is defined as a permanent cessation of menstruation resulting from loss of activity of ovarian follicles. In a majority of women, menopause is a natural event occurring at the age of around 51.3 years. The number of women entering the menopause stage is increasing due to unhealthy lifestyle and different environmental factors. Presently, over5 millionwomen in Canada aged between 45 and 65 either have gone through menopause or will soon do. The average age of menopause in Canada is 51 years.

Request Brochure for Report https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=63339

Favorable Incentive and Reimbursement Policies for UTIs to Augment Market

Incentive policies for antibiotic consumption are favoring the urinary tract infection (UTI) treatment market, as governments of most countries approve the use of antibiotics in UTI treatment and provide reimbursement for it. Economic incentives are also provided all along the supply chain, which consists of distributors, suppliers, hospitals, clinics, and communities. Over80%of antibiotics are used in countries where purchasing of antibiotics without prescription is common. These include countries such as India, China, and other low- and middle-income countries.

Risk of Breast Cancer Due to HRT Treatment to Restrain Market

Risk of breast cancer associated with hormone replacement therapy (HRT) treatment has been one of the leading challenges in the past few years. HRT is an effective short-term treatment for menopausal symptoms; however, it increases the risk of breast cancer. Incidence rate of breast cancer has dropped sharply in the U.S., as a large number of women have stopped using menopausal hormones. Decline in adoption of HRT treatment can negatively affect the global womens health diagnostics market.

Request for Analysis of COVID19 Impact on Womens Health Diagnostics Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=63339

Asia Pacific Womens Health Diagnostics Market to Expand Significantly

Rise in prevalence of cancer & infectious diseases, increase in collaborations between hospitals and tissue banks, and surge in investments in research & development are likely to drive the womens health diagnostics market in Asia Pacific during the forecast period. This market in Asia Pacific is likely to expand at a high CAGR from2019to2027. Growth of the womens health diagnostics market in the region can be attributed to increase in health coverage, rise in healthcare expenditure, surge in awareness among people, and government initiatives

Buy Womens Health Diagnostics Market Report https://www.transparencymarketresearch.com/checkout.php?rep_id=63339&ltype=S

Competition Landscape

The report also provides profiles of leading players operating in the global womens health diagnostics market. These include Abbott Laboratories, Becton, Dickinson and Company, bioMrieux SA, F. Hoffmann-La Roche AG, GE Healthcare, Hologic, Inc., Koninklijke Philips N.V., Quest Diagnostics, Inc., Cardinal Health, and Siemens AG.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

See the rest here:
Women's Health Diagnostics Market projected to expand at a CAGR of ~6% from 2019 to 2027 - The Think Curiouser

Related Post